0001415889-23-013036.txt : 20230906 0001415889-23-013036.hdr.sgml : 20230906 20230906185323 ACCESSION NUMBER: 0001415889-23-013036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boudreau Philip P CENTRAL INDEX KEY: 0001805099 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 231240592 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-09062023_100916.xml X0508 4 2023-09-01 0000001800 ABBOTT LABORATORIES ABT 0001805099 Boudreau Philip P 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false SENIOR VICE PRESIDENT 0 Common shares without par value 2023-09-01 4 A 0 2620 0 A 18067 D Common shares without par value 349 I Profit Sharing Trust Option (right to buy) 103.18 2023-09-01 4 A 0 10223 0 A 2024-09-01 2033-08-31 Common Shares 10223 10223 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2023. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 3,407 on September 1, 2024, 3,408 on September 1, 2025, and 3,408 on September 1, 2026. /s/ Philip P. Boudreau, by Jessica H. Paik, Attorney-in-Fact 2023-09-06